COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe - EPA:CRI - FR0000130692 - Common Stock
11.06 EUR
+0.06 (+0.55%)
CRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CRI was profitable.
In the past year CRI had a positive cash flow from operations.
Of the past 5 years CRI 4 years were profitable.
In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of 0.26%, CRI is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
The Return On Equity of CRI (0.96%) is worse than 66.67% of its industry peers.
CRI's Return On Invested Capital of 5.19% is in line compared to the rest of the industry. CRI outperforms 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 6.08%.
The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.19%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROIC | 5.19% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
With a Profit Margin value of 0.34%, CRI is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
CRI's Profit Margin has declined in the last couple of years.
CRI has a worse Operating Margin (6.46%) than 60.00% of its industry peers.
In the last couple of years the Operating Margin of CRI has remained more or less at the same level.
CRI has a worse Gross Margin (28.51%) than 80.00% of its industry peers.
CRI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRI is destroying value.
CRI has more shares outstanding than it did 1 year ago.
CRI has more shares outstanding than it did 5 years ago.
CRI has a better debt/assets ratio than last year.
2.2 Solvency
CRI has an Altman-Z score of 1.26. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
CRI's Altman-Z score of 1.26 is on the low side compared to the rest of the industry. CRI is outperformed by 93.33% of its industry peers.
CRI has a debt to FCF ratio of 131.84. This is a negative value and a sign of low solvency as CRI would need 131.84 years to pay back of all of its debts.
With a Debt to FCF ratio value of 131.84, CRI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.38 is on the high side and indicates that CRI has dependencies on debt financing.
The Debt to Equity ratio of CRI (1.38) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Altman-Z | 1.26 |
ROIC/WACC0.8
WACC6.51%
2.3 Liquidity
CRI has a Current Ratio of 1.30. This is a normal value and indicates that CRI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, CRI is doing worse than 73.33% of the companies in the same industry.
CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.86, CRI is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 146.24%, which is quite impressive.
CRI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.59% yearly.
CRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.67%.
CRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.10% yearly.
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
Based on estimates for the next years, CRI will show a very strong growth in Earnings Per Share. The EPS will grow by 48.09% on average per year.
CRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y68.78%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPS Next 5YN/A
Revenue Next Year5.01%
Revenue Next 2Y5.88%
Revenue Next 3Y4.86%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CRI is valuated quite expensively with a Price/Earnings ratio of 92.17.
Based on the Price/Earnings ratio, CRI is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
CRI is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
CRI is valuated reasonably with a Price/Forward Earnings ratio of 10.55.
80.00% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.88. CRI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 92.17 | ||
| Fwd PE | 10.55 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRI indicates a somewhat cheap valuation: CRI is cheaper than 73.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRI indicates a slightly more expensive valuation: CRI is more expensive than 66.67% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.03 | ||
| EV/EBITDA | 7.51 |
4.3 Compensation for Growth
CRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRI's earnings are expected to grow with 48.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.34
PEG (5Y)N/A
EPS Next 2Y54.04%
EPS Next 3Y48.09%
5. Dividend
5.1 Amount
CRI has a Yearly Dividend Yield of 1.13%.
Compared to an average industry Dividend Yield of 13.88, CRI's dividend is way lower than its industry peers. On top of this 80.00% of the companies listed in the same industry pay a better dividend than CRI!
With a Dividend Yield of 1.13, CRI pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
128.00% of the earnings are spent on dividend by CRI. This is not a sustainable payout ratio.
DP128%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPA:CRI (9/19/2025, 3:48:31 PM)
11.06
+0.06 (+0.55%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)
Earnings (Next)
Inst Owners9.98%
Inst Owner ChangeN/A
Ins Owners64.27%
Ins Owner ChangeN/A
Market Cap275.28M
Analysts75
Price Target13.09 (18.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP128%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.85%
PT rev (3m)-4.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-31.57%
EPS NY rev (3m)-31.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.72%
Revenue NY rev (3m)-3.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 92.17 | ||
| Fwd PE | 10.55 | ||
| P/S | 0.38 | ||
| P/FCF | 86.03 | ||
| P/OCF | 11.76 | ||
| P/B | 1.05 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.51 |
EPS(TTM)0.12
EY1.08%
EPS(NY)1.05
Fwd EY9.47%
FCF(TTM)0.13
FCFY1.16%
OCF(TTM)0.94
OCFY8.5%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)1.34
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.26% | ||
| ROE | 0.96% | ||
| ROCE | 7.08% | ||
| ROIC | 5.19% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 13.23% | ||
| OM | 6.46% | ||
| PM (TTM) | 0.34% | ||
| GM | 28.51% | ||
| FCFM | 0.44% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexcg growth 3Y-6.3%
ROICexcg growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 131.84 | ||
| Debt/EBITDA | 4.62 | ||
| Cap/Depr | 65.16% | ||
| Cap/Sales | 2.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30% | ||
| Profit Quality | 128% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.26 |
F-Score7
WACC6.51%
ROIC/WACC0.8
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)146.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y68.78%
EPS Next 2Y54.04%
EPS Next 3Y48.09%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year5.01%
Revenue Next 2Y5.88%
Revenue Next 3Y4.86%
Revenue Next 5YN/A
EBIT growth 1Y57.72%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year145.94%
EBIT Next 3Y48.76%
EBIT Next 5YN/A
FCF growth 1Y109.04%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y241.82%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%